Clinical trial · Interventional
Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients
Study of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients
NCT00955058CI-TRIAL-00002599PSAunknownPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compound.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| OCP | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- cyproterone compound
- description
- Before and after treatment
- interventionNames
- Drug: OCP
- type
- EXPERIMENTAL
- label
- oral contraceptive pill
- description
- Treatment
- interventionNames
- Drug: OCP
Primary outcomes (1)
- measure
- Serum free PSA was measured by ultrasensitive chemiluminnicsence enzyme immunoassay
- timeFrame
- 3 MONTHS
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 22 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * PCOS patients Exclusion Criteria: * Women who received hormone therapy during the last 3 months, * On a diet * Herbal treatment * Hyperprolactinemia * Thyroid disorders * Ovarian tumors * Cushing disease.
References
Publications (0)
Data not yet available
No reference posted for this study.